BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease
about
BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease
description
clinical trial
@en
klinisch onderzoek
@nl
name
BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease
@en
type
label
BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease
@en
prefLabel
BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease
@en
P17
P1476
An Open-label Phase IIa, Non-r ...... Suitable for Endocrine Therapy
@en
P3098
NCT01070485
P580
2010-01-01T00:00:00Z
P582
2011-03-01T00:00:00Z